Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-02
DOI
10.1007/s12016-020-08802-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
- (2020) Emma Guttman-Yassky et al. JAMA Dermatology
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- (2019) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
- (2018) Kenji Kabashima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
- (2018) Alison D. Treister et al. JAMA Dermatology
- An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
- (2017) Benjamin Ungar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
- (2016) Saakshi Khattri et al. EXPERIMENTAL DERMATOLOGY
- Control of the Physical and Antimicrobial Skin Barrier by an IL-31–IL-1 Signaling Network
- (2016) Kai H. Hänel et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
- (2016) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab as a treatment for severe atopic eczema: failure to improve in three consecutive patients
- (2015) B. S. McDonald et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Associations of Childhood Eczema Severity
- (2014) Jonathan I. Silverberg et al. Dermatitis
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Thymic stromal lymphopoietin–mediated epicutaneous inflammation promotes acute diarrhea and anaphylaxis
- (2014) Hongwei Han et al. JOURNAL OF CLINICAL INVESTIGATION
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2014) Robert Sidbury et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Protease Activity Enhances Production of Thymic Stromal Lymphopoietin and Basophil Accumulation in Flaky Tail Mice
- (2013) Catharina S. Moniaga et al. AMERICAN JOURNAL OF PATHOLOGY
- The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
- (2013) Sarah R. Wilson et al. CELL
- Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial
- (2013) Shuba Rajashri Iyengar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study
- (2013) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic dermatitis: A practice parameter update 2012
- (2013) Lynda Schneider et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
- (2013) Ferda Cevikbas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- Anti-IgE therapy and severe atopic dermatitis: A pediatric perspective
- (2013) Jonathan Lacombe Barrios et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population
- (2011) Jung-Hyun Namkung et al. EXPERIMENTAL DERMATOLOGY
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health
- (2010) Tatyana E. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study
- (2008) Lee E. Sheinkopf et al. ALLERGY AND ASTHMA PROCEEDINGS
- Anti-CD20 (rituximab) treatment for atopic eczema
- (2008) Anna Šedivá et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-CD20 (rituximab) treatment improves atopic eczema
- (2008) Dagmar Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now